Sotera Health Company(SHC)Earnings, Financials & Key Ratios

SHC•NASDAQ

$15.80

$4.51B mkt cap·58.5× P/E·Price updated May 6, 2026

SectorHealthcare IndustryDiagnostics & Research Sub-IndustryClinical and Specialty Lab Testing

AboutSotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.Show more

Revenue$1.16B+5.7%
EBITDA$303M-34.3%
Net Income$78M+75.6%
EPS (Diluted)0.27+68.8%
Gross Margin55.48%+1.4%
EBITDA Margin26.06%-37.8%
Operating Margin33.75%+24.8%
Net Margin6.7%+66.0%
ROE15.42%+47.4%
ROIC11.76%+30.4%
Debt/Equity3.75-35.4%
Interest Coverage1.95+15.1%

Technical→

SHC Key Insights

Sotera Health Company (SHC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

✗High debt to equity ratio of 3.8x
✗Thin 5Y average net margin of 1.0%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

SHC Price & Volume

Sotera Health Company (SHC) stock price & volume — 10-year historical chart

Loading chart...

SHC Growth Metrics

Sotera Health Company (SHC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years7.3%

3 Years5.05%

TTM7.44%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM374.7%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM369.39%

Return on Capital

10 Years9.08%

5 Years10.8%

3 Years11.4%

Last Year13.33%

SHC Recent Earnings

Sotera Health Company (SHC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 7/12 qtrs (58%)●Beat Revenue 7/12 qtrs (58%)

Q2 2026Latest

May 5, 2026

EPS

$0.18

Est $0.17

+5.9%

Revenue

$280M

Est $271M

+3.4%

Q1 2026

Feb 24, 2026

EPS

$0.26

Est $0.24

+8.3%

Revenue

$303M

Est $299M

+1.3%

Q4 2025

Nov 4, 2025

EPS

$0.26

Est $0.22

+18.2%

Revenue

$311M

Est $300M

+3.9%

Q3 2025

Aug 8, 2025

EPS

$0.20

Est $0.17

+17.6%

Revenue

$294M

Est $305M

-3.5%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 5, 2026	$0.18vs $0.17+5.9%	$280Mvs $271M+3.4%
Q1 2026	Feb 24, 2026	$0.26vs $0.24+8.3%	$303Mvs $299M+1.3%
Q4 2025	Nov 4, 2025	$0.26vs $0.22+18.2%	$311Mvs $300M+3.9%
Q3 2025	Aug 8, 2025	$0.20vs $0.17+17.6%	$294Mvs $305M-3.5%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
STRLSterling Infrastructure, Inc.Direct Competitor	27.19B	886.22	94.48	17.69%	12.02%	32.26%	0.32
ICLRICON Public Limited CompanyDirect Competitor	9.48B	124.13	13.03	1.99%	7.4%	6.32%	0.38
CRLCharles River Laboratories International, Inc.Direct Competitor	8.97B	181.73	-62.45	-0.85%	-3.59%	-4.34%	0.95
MEDPMedpace Holdings, Inc.Direct Competitor	12.19B	426.79	27.93	19.97%	17.19%	120.89%	0.55
PINCPremier, Inc.Direct Competitor	2.34B	28.26	128.45	-10.86%	-2.42%	-1.59%	0.18
BCOThe Brink's CompanyProduct Competitor	4.49B	109.01	23.19	4.97%	3.34%	42.08%	12.10
BRKRBruker CorporationProduct Competitor	6.44B	42.30	-282	2.08%	-0.75%	-1.11%	0.81
NEOGNeogen CorporationProduct Competitor	2B	9.18	-1.83	-3.2%	-68.47%	-28.64%	0.44

Compare SHC vs Peers

Sotera Health Company (SHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs STRL

Most directly comparable listed peer for SHC.

Scale Benchmark

vs MMM

Larger-name benchmark to compare SHC against a more recognizable public peer.

Peer Set

Compare Top 5

vs STRL, ICLR, CRL, MEDP

SHC Income Statement

Sotera Health Company (SHC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	746.15M	778.33M	818.16M	931.48M	1B	1.05B	1.1B	1.16B	1.19B
Revenue Growth %	-	4.31%	5.12%	13.85%	7.75%	4.54%	4.88%	5.74%	7.44%
Cost of Goods Sold	388.9M	382.9M	374.59M	412.81M	446.68M	472.13M	498.15M	518.08M	531.97M
COGS % of Revenue	52.12%	49.19%	45.78%	44.32%	44.5%	45%	45.27%	44.52%	-
Gross Profit	357.25M▲ 0%	395.43M▲ 10.7%	443.57M▲ 12.2%	518.67M▲ 16.9%	557M▲ 7.4%	577.16M▲ 3.6%	602.29M▲ 4.4%	645.53M▲ 7.2%	657.17M▲ 0%
Gross Margin %	47.88%	50.81%	54.22%	55.68%	55.5%	55%	54.73%	55.48%	55.26%
Gross Profit Growth %	-	10.69%	12.17%	16.93%	7.39%	3.62%	4.36%	7.18%	-
Operating Expenses	191.34M	211.83M	237.55M	261.94M	308.65M	300.47M	304.67M	252.76M	242.59M
OpEx % of Revenue	25.64%	27.22%	29.04%	28.12%	30.75%	28.64%	27.69%	21.72%	-
Selling, General & Admin	133.36M	147.48M	178.53M	198.16M	245.71M	236.67M	242.63M	252.76M	257.91M
SG&A % of Revenue	17.87%	18.95%	21.82%	21.27%	24.48%	22.55%	22.05%	21.72%	-
Research & Development	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-
Other Operating Expenses	143.04M	64.35M	59.03M	63.78M	62.94M	63.8M	62.04M	0	1000K
Operating Income	80.85M▲ 0%	183.6M▲ 127.1%	206.02M▲ 12.2%	256.73M▲ 24.6%	248.35M▼ 3.3%	276.69M▲ 11.4%	297.63M▲ 7.6%	392.77M▲ 32.0%	414.59M▲ 0%
Operating Margin %	10.84%	23.59%	25.18%	27.56%	24.74%	26.37%	27.05%	33.75%	34.86%
Operating Income Growth %	-	127.09%	12.21%	24.62%	-3.27%	11.41%	7.57%	31.97%	-
EBITDA	227.66M	330.32M	349.58M	407.63M	393.9M	434.62M	461.26M	303.23M	517.3M
EBITDA Margin %	30.51%	42.44%	42.73%	43.76%	39.25%	41.42%	41.92%	26.06%	43.5%
EBITDA Growth %	-	45.09%	5.83%	16.61%	-3.37%	10.34%	6.13%	-34.26%	11.13%
D&A (Non-Cash Add-back)	146.82M	146.72M	143.56M	150.9M	145.55M	157.93M	163.64M	0	102.72M
EBIT	167.55M	156.81M	176.4M	249.91M	-162.97M	248.91M	278.56M	303.23M	277.18M
Net Interest Income	-143.33M	-157.73M	-215.26M	-74.19M	-80.14M	-142.88M	-164.69M	-155.72M	-114.93M
Interest Income	0	0	0	0	0	0	0	0	0
Interest Expense	143.33M	157.73M	215.26M	74.19M	80.14M	142.88M	164.69M	155.72M	149.59M
Other Income/Expense	-56.63M	-184.51M	-244.88M	-81.02M	-491.46M	-170.66M	-183.75M	-245.27M	-209.64M
Pretax Income	24.22M▲ 0%	-916K▼ 103.8%	-38.86M▼ 4142.4%	175.72M▲ 552.2%	-243.11M▼ 238.4%	106.03M▲ 143.6%	113.87M▲ 7.4%	147.51M▲ 29.5%	204.94M▲ 0%
Pretax Margin %	3.25%	-0.12%	-4.75%	18.86%	-24.22%	10.1%	10.35%	12.68%	17.23%
Income Tax	30.1M	19.51M	-1.37M	58.59M	-9.54M	54.65M	69.48M	69.56M	87.14M
Effective Tax Rate %	124.26%	-2129.8%	3.52%	33.35%	3.92%	51.54%	61.01%	47.16%	42.52%
Net Income	-5.87M▲ 0%	-20.85M▼ 255.2%	-38.62M▼ 85.2%	116.88M▲ 402.7%	-233.57M▼ 299.8%	51.38M▲ 122.0%	44.4M▼ 13.6%	77.95M▲ 75.6%	117.8M▲ 0%
Net Margin %	-0.79%	-2.68%	-4.72%	12.55%	-23.27%	4.9%	4.03%	6.7%	9.91%
Net Income Growth %	-	-255.2%	-85.21%	402.67%	-299.83%	122%	-13.58%	75.57%	374.7%
Net Income (Continuing)	-5.88M	-20.43M	-37.49M	117.12M	-233.57M	51.38M	44.4M	77.95M	117.8M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	1.13M	1.44M	2.27M	0	0	0	0	0	0
EPS (Diluted)	-0.02▲ 0%	-0.07▼ 201.7%	-0.14▼ 95.0%	0.41▲ 392.9%	-0.83▼ 302.4%	0.18▲ 121.7%	0.16▼ 11.1%	0.27▲ 68.8%	0.41▲ 0%
EPS Growth %	-	-201.68%	-94.99%	392.86%	-302.44%	121.69%	-11.11%	68.75%	369.39%
EPS (Basic)	-0.02	-0.07	-0.14	0.41	-0.83	0.18	0.16	0.27	-
Diluted Shares Outstanding	246.15M	284.42M	283.25M	279.38M	280.1M	283.22M	284.91M	286.42M	287.62M
Basic Shares Outstanding	246.15M	284.42M	283.25M	279.23M	280.1M	281.01M	282.78M	283.96M	284.89M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-

SHC Balance Sheet

Sotera Health Company (SHC) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	312.86M	252.35M	315.01M	345.96M	645.01M	557.24M	526.04M	613.41M	585.97M
Cash & Short-Term Investments	96.27M	62.86M	102.45M	106.92M	395.21M	296.41M	277.24M	346.46M	315.94M
Cash Only	96.27M	62.86M	102.45M	106.92M	395.21M	296.41M	277.24M	346.46M	315.94M
Short-Term Investments	0	0	0	0	0	0	0	0	0
Accounts Receivable	141.61M	111.58M	131.02M	134.05M	155.72M	175.52M	165.81M	176.27M	137.26M
Days Sales Outstanding	69.27	52.33	58.45	52.53	56.63	61.06	55	55.29	52.83
Inventory	37.6M	37.4M	34.09M	54.29M	37.15M	48.32M	49.16M	54.38M	57.49M
Days Inventory Outstanding	35.29	35.65	33.22	48	30.35	37.35	36.02	38.31	38.9
Other Current Assets	12.15M	10.84M	10.74M	11.19M	16.56M	20.91M	16.58M	36.31M	75.28M
Total Non-Current Assets	2.4B	2.33B	2.45B	2.44B	2.47B	2.57B	2.55B	2.65B	2.65B
Property, Plant & Equipment	586.44M	581.95M	655.78M	690.74M	801.01M	970.95M	1.06B	1.16B	1.18B
Fixed Asset Turnover	1.27x	1.34x	1.25x	1.35x	1.25x	1.08x	1.03x	1.00x	1.04x
Goodwill	1.02B	1.04B	1.12B	1.12B	1.1B	1.11B	1.08B	1.1B	1.1B
Intangible Assets	766.05M	696.01M	643.37M	598.84M	491.26M	416.32M	317.65M	288.23M	279.36M
Long-Term Investments	0	0	13.46M	9.4M	0	0	0	0	0
Other Non-Current Assets	4.15M	12.24M	9.3M	18.34M	74.55M	69.72M	79.58M	94.36M	365.4M
Total Assets	2.71B▲ 0%	2.58B▼ 4.7%	2.76B▲ 7.0%	2.79B▲ 1.0%	3.12B▲ 11.8%	3.13B▲ 0.4%	3.07B▼ 1.9%	3.26B▲ 6.2%	3.24B▲ 0%
Asset Turnover	0.28x	0.30x	0.30x	0.33x	0.32x	0.34x	0.36x	0.36x	0.37x
Asset Growth %	-	-4.72%	7%	1.02%	11.77%	0.41%	-1.88%	6.24%	17.09%
Total Current Liabilities	143.37M	123.99M	140.6M	161.16M	791.57M	230.65M	191M	249.58M	207.8M
Accounts Payable	46.35M	42M	52.4M	72.87M	74.14M	71.04M	55.1M	77.96M	0
Days Payables Outstanding	43.51	40.04	51.06	64.43	60.58	54.92	40.37	54.93	34.82
Short-Term Debt	15.34M	16.33M	0	0	197.12M	4.8M	14.8M	13.97M	23.35M
Deferred Revenue (Current)	4.62M	3.63M	6.06M	8.67M	12.14M	13.49M	15.1M	0	25.59M
Other Current Liabilities	50.65M	37.34M	38.8M	37.21M	43.12M	36.93M	41.12M	142.74M	184.46M
Current Ratio	2.18x	2.04x	2.24x	2.15x	0.81x	2.42x	2.75x	2.46x	2.46x
Quick Ratio	1.92x	1.73x	2.00x	1.81x	0.77x	2.21x	2.50x	2.24x	2.24x
Cash Conversion Cycle	61.06	47.93	40.61	36.1	26.4	43.49	50.64	38.67	56.91
Total Non-Current Liabilities	2.52B	3.1B	2.17B	2.04B	1.98B	2.46B	2.48B	2.41B	2.41B
Long-Term Debt	2.19B	2.8B	1.82B	1.74B	1.75B	2.22B	2.21B	2.13B	2.25B
Capital Lease Obligations	31.54M	29.88M	73.88M	73.89M	78.53M	83.88M	119.75M	123.74M	372.63M
Deferred Tax Liabilities	171.48M	137.24M	121.82M	134.5M	68.02M	64.45M	69.5M	71.08M	248.5M
Other Non-Current Liabilities	106.18M	108.45M	124.37M	69.57M	63.33M	65.26M	61.6M	68.98M	362.83M
Total Liabilities	2.66B	3.22B	2.31B	2.2B	2.77B	2.69B	2.67B	2.66B	2.61B
Total Debt	2.24B	2.85B	1.91B	1.83B	2.03B	2.33B	2.35B	2.27B	2.27B
Net Debt	2.14B	2.79B	1.81B	1.72B	1.64B	2.03B	2.07B	1.93B	1.95B
Debt / Equity	49.19x	-	4.20x	3.12x	5.80x	5.24x	5.81x	3.75x	3.75x
Debt / EBITDA	9.83x	8.62x	5.46x	4.48x	5.16x	5.35x	5.10x	7.50x	4.39x
Net Debt / EBITDA	9.41x	8.43x	5.17x	4.22x	4.16x	4.67x	4.50x	6.36x	6.36x
Interest Coverage	1.17x	0.99x	0.82x	3.37x	-2.03x	1.74x	1.69x	1.95x	1.85x
Total Equity	45.49M▲ 0%	-641.13M▼ 1509.4%	454.57M▲ 170.9%	586.1M▲ 28.9%	350.24M▼ 40.2%	443.73M▲ 26.7%	404.91M▼ 8.7%	606.03M▲ 49.7%	622.5M▲ 0%
Equity Growth %	-	-1509.36%	170.9%	28.93%	-40.24%	26.7%	-8.75%	49.67%	138.02%
Book Value per Share	0.18	-2.25	1.60	2.10	1.25	1.57	1.42	2.12	2.16
Total Shareholders' Equity	44.36M	-642.57M	452.3M	586.1M	350.24M	443.73M	404.91M	606.03M	622.5M
Common Stock	2.32M	2.32M	2.86M	2.86M	2.86M	2.86M	2.86M	2.86M	2.86M
Retained Earnings	-10.42M	-550.51M	-589.13M	-472.25M	-705.82M	-654.44M	-610.04M	-532.09M	-505.5M
Treasury Stock	0	0	-34M	-33.55M	-29.77M	-27.18M	-23.43M	-17.01M	0
Accumulated OCI	-109.96M	-94.39M	-93.84M	-83.57M	-106.65M	-92.68M	-208.25M	-109.84M	-125.94M
Minority Interest	1.13M	1.44M	2.27M	0	0	0	0	0	0

SHC Cash Flow Statement

Sotera Health Company (SHC) cash flow — operating, investing & free cash flow history

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	119.56M	149.04M	120.58M	281.55M	277.96M	-147.73M	224.16M	287.19M	287.19M
Operating CF Margin %	16.02%	19.15%	14.74%	30.23%	27.69%	-14.08%	20.37%	24.68%	-
Operating CF Growth %	-	24.65%	-19.09%	133.48%	-1.27%	-153.15%	251.74%	28.12%	-49.34%
Net Income	-5.88M	-20.43M	-37.49M	117.12M	-233.57M	51.38M	44.4M	77.95M	117.8M
Depreciation & Amortization	146.82M	146.72M	143.56M	150.9M	145.55M	160.34M	163.64M	0	127.18M
Stock-Based Compensation	6.94M	6.88M	10.99M	13.87M	21.21M	32.24M	36.78M	0	23.77M
Deferred Taxes	-45.32M	-18.99M	-23.36M	-3.72M	-73.96M	3.45M	9.43M	0	-9.02M
Other Non-Cash Items	12.96M	43.21M	38.68M	15.96M	9.49M	8.15M	12.55M	181.2M	96.33M
Working Capital Changes	4.04M	-8.35M	-11.79M	-12.59M	409.23M	-403.29M	-42.63M	28.04M	-16.59M
Change in Receivables	-2.91M	11.76M	1.94M	-15.51M	-12.55M	-21.72M	2.22M	7.15M	-51K
Change in Inventory	-7.04M	-282K	3.78M	-20.25M	14.44M	-9.97M	-4.75M	-2.38M	422K
Change in Payables	15.13M	-8.97M	-6.02M	19.76M	1.11M	-5.33M	-6.64M	5.18M	1.89M
Cash from Investing	96.64M	-57.26M	-158.69M	-159.83M	-181.9M	-214.91M	-179M	-135.14M	-115.26M
Capital Expenditures	-72.61M	-57.26M	-53.51M	-102.16M	-182.38M	-214.97M	-179.07M	-138.02M	-118.1M
CapEx % of Revenue	9.73%	7.36%	6.54%	10.97%	18.17%	20.49%	16.27%	11.86%	-
Acquisitions	162.82M	0	-105.19M	-56.97M	450K	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-
Other Investing	6.43M	0	0	-701K	32K	69K	74K	2.87M	2.84M
Cash from Financing	-191.86M	-126.03M	73.43M	-117.29M	197.76M	265.96M	-50.56M	-100.53M	-90.4M
Debt Issued (Net)	-14.63M	583.52M	-1.03B	-100M	200M	297.5M	-11.76M	-86.1M	-85.89M
Equity Issued (Net)	0	0	1.12B	-1.43M	-393K	-4.09M	-4.43M	0	-54K
Dividends Paid	-175.84M	-691.17M	0	0	0	0	0	0	0
Share Repurchases	0	0	-34M	-1.43M	-393K	-4.09M	-4.43M	0	-54K
Other Financing	-1.38M	-18.38M	-21.2M	-15.85M	-1.85M	-27.45M	-34.38M	-14.43M	-4.46M
Net Change in Cash	20.67M▲ 0%	-33.76M▼ 263.3%	39.43M▲ 216.8%	4.47M▼ 88.7%	289.37M▲ 6373.6%	-94.64M▼ 132.7%	-22.79M▲ 75.9%	67.59M▲ 396.6%	9.86M▲ 0%
Free Cash Flow	46.95M▲ 0%	91.78M▲ 95.5%	67.08M▼ 26.9%	179.38M▲ 167.4%	95.58M▼ 46.7%	-362.71M▼ 479.5%	45.09M▲ 112.4%	149.18M▲ 230.8%	111.53M▲ 0%
FCF Margin %	6.29%	11.79%	8.2%	19.26%	9.52%	-34.57%	4.1%	12.82%	9.38%
FCF Growth %	-	95.49%	-26.92%	167.42%	-46.72%	-479.47%	112.43%	230.81%	7.2%
FCF per Share	0.19	0.32	0.24	0.64	0.34	-1.28	0.16	0.52	0.52
FCF Conversion (FCF/Net Income)	-20.37x	-7.15x	-3.12x	2.41x	-1.19x	-2.88x	5.05x	3.68x	0.95x
Interest Paid	138.85M	151M	211.28M	58.77M	75.85M	173.84M	179.92M	0	55.3M
Taxes Paid	68.61M	44.61M	23.99M	52.01M	75.5M	50.21M	65.83M	0	19.99M

SHC Key Ratios

Sotera Health Company (SHC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	-	-8.5%	22.46%	-49.89%	12.94%	10.46%	15.42%	20.57%
Return on Invested Capital (ROIC)	6.36%	7.01%	8.43%	8.68%	9.3%	9.01%	11.76%	11.76%
Gross Margin	50.81%	54.22%	55.68%	55.5%	55%	54.73%	55.48%	55.26%
Net Margin	-2.68%	-4.72%	12.55%	-23.27%	4.9%	4.03%	6.7%	9.91%
Debt / Equity	-	4.20x	3.12x	5.80x	5.24x	5.81x	3.75x	3.75x
Interest Coverage	0.99x	0.82x	3.37x	-2.03x	1.74x	1.69x	1.95x	1.85x
FCF Conversion	-7.15x	-3.12x	2.41x	-1.19x	-2.88x	5.05x	3.68x	0.95x
Revenue Growth	4.31%	5.12%	13.85%	7.75%	4.54%	4.88%	5.74%	7.44%

SHC SEC Filings & Documents

Sotera Health Company (SHC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 5, 2026·SEC

Material company update

Mar 16, 2026·SEC

Material company update

Mar 6, 2026·SEC

10-K Annual Reports

FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 27, 2025·SEC

FY 2024

Feb 27, 2024·SEC

10-Q Quarterly Reports

FY 2026

May 5, 2026·SEC

FY 2025

Nov 4, 2025·SEC

FY 2025

Aug 8, 2025·SEC

SHC Frequently Asked Questions

Sotera Health Company (SHC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Sotera Health Company (SHC) reported $1.19B in revenue for fiscal year 2025. This represents a 59% increase from $746.1M in 2018.

Sotera Health Company (SHC) grew revenue by 5.7% over the past year. This is steady growth.

Yes, Sotera Health Company (SHC) is profitable, generating $117.8M in net income for fiscal year 2025 (6.7% net margin).

Dividend & Returns

Sotera Health Company (SHC) has a return on equity (ROE) of 15.4%. This is reasonable for most industries.

Sotera Health Company (SHC) generated $111.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More SHC

Sotera Health Company (SHC) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Sotera Health Company(SHC)Earnings, Financials & Key Ratios

SHC Key Insights

✓Strengths

✗Weaknesses

SHC Price & Volume

SHC Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

SHC Recent Earnings

SHC Peer Comparison

Compare SHC vs Peers

vs STRL

vs MMM

Compare Top 5

SHC Income Statement

SHC Balance Sheet

SHC Cash Flow Statement

SHC Key Ratios

SHC SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

SHC Frequently Asked Questions

Explore More SHC

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation